Head and Neck Carcinoma Clinical Trials & Research at Providence Medical Group

Head and neck cancers start in the tissues and organs of the head and neck and include cancers of the larynx (voice box), throat, lips, mouth, nose, and salivary glands. Most head and neck cancers are squamous cell carcinomas and begin in the moist tissues that line the mouth, nose and throat. Tobacco use, heavy alcohol use, and infection with the human papillomavirus (HPV) increase your risk of head and neck cancer.

Providence Medical Group is currently enrolling patients for the following head and neck carcinoma clinical trials at this time:

Evolve study for participants with unresected locally advanced head and neck squamous cell carcinoma, who have not progressed following definitive concurrent chemoradiotherapy

Treatment agent: Volrustomig (MEDI5752) as Sequential Therapy Versus Observation
Physician: Dr. Yao Yao Pollock
Study Coordinator: Tracy Foster // tracy.foster@stjoe.org // 707-521-3830
Study Resources: Study Details | A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy | ClinicalTrials.gov
Sponsor: AstraZeneca
Location: Providence Cancer Center, Santa Rosa, CA